Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Until recently in its history, Range Resources' balance sheet was a persistent cause for concern. But the recent focus on disciplined capital allocation has paid off. The windfall from the 2022 surge ...